2119. Predictive Value of the Immunodeficiency Scoring Index for COVID-19 Related Outcomes in Hematopoietic Transplant Recipients

por Daher, Marilyne, Khawaja, Fareed, Angelidakis, Georgios, Rondon, Gabriella, Spallone, Amy, Ramdial, Jeremy, Ariza-Heredia, Ella, Shpall, Elizabeth, Chemaly, Roy F
Publicado 2022

2122. The Impact of HHV-6 DNAemia on hematopoietic cell transplant (HCT) recipients at high risk for CMV reactivation in the era of Letermovir

por Srinivasan, Krithia, Spallone, Amy, Khawaja, Fareed, Sassine, Joseph, Aramburo, Oscar Morado, Febres-Aldana, Anthony J, Rondon, Gabriella, Ramdial, Jeremy, Shpall, Elizabeth, Ariza-Heredia, Ella, Chemaly, Roy F
Publicado 2022

1995. Duration of letermovir primary prophylaxis in hematopoietic cell transplant recipients at high risk for cytomegalovirus infections and impact on outcomes

por Febres-Aldana, Anthony J, Khawaja, Fareed, Spallone, Amy, Srinivasan, Krithika, Lynn Shigle, Terri, Morado Aramburo, Oscar, Rondon, Gabriella, Ramdial, Jeremy, Shpall, Elizabeth, Ariza Heredia, Ella, Chemaly, Roy F, Sassine, Joseph
Publicado 2023

2121. The Impact of Donor CMV Serostatus on Outcomes of CMV Infections in the Era of Letermovir

por Aramburo, Oscar Morado, Spallone, Amy, Khawaja, Fareed, Sassine, Joseph, Srinivasan, Krithia, Febres-Aldana, Anthony J, Shigle, Terri Lynn, Rondon, Gabriella, Ramdial, Jeremy, Shpall, Elizabeth, Ariza-Heredia, Ella, Chemaly, Roy F
Publicado 2022